Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus

NCT05860413 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Kansas Medical Center

Collaborators